Revenue FY2025
—
Net Income
$(90.0M)
EPS (Basic)
$-2.12
Net Margin
—
ROE
-60.8%
Total Equity
$147.0M
Shares Out
69M
PepGen Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2021–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$36.1M
0.2%
—
Vivo Capital
Vivo Capital
$4.2M
0.1%
—
Viking Global Investors
Andreas Halvorsen
$6.3M
0.0%
—
Insider Transactions
Reading stored insider transactions…